1278 results
Treatment of giant cell arteritis (GCA)

1st Line Strategy - GC 0.7 mg/kg/day, except for:
 • Aortitis
Treatment of giant ... necrosis, stroke) Relapses ... • 1st relapse: Incr ... mg/jd • 2nd relapse ... arteritis #GCA #Treatment
Multiple Myeloma - Management Algorithms
 - Treatment Initiation
 - Frontline Treatment
 - First Relapse
 - Second
Algorithms - Treatment ... - Frontline Treatment ... - First Relapse ... Second or Higher Relapse ... #relapse #initiation
Global Alliance algorithm to improve outcomes in acne.
†With small nodules (>0.5–1 cm).
‡Consider physical removal of comedones.
§Second
course in case of relapse ... PrimaryCare #Acne #Treatment
IgG4-Related Disease
Clinical history:  Man, 60 years, multiorgan involvement, unique or multiple inflammatory pseudotumor
4 phenotypes:
 •
with response to treatment ... and relapse No ... IgG4+ cells" Treatment ... 0.6 mg/kg/day) - Relapse ... phenotypes #workup #treatment
Autoimmune Hemolytic Anemia (AIHA) Treatment
Warm AIHA:
1) Steroids - 1-2 mg/kg prednisone daily
   • Until
Anemia (AIHA) Treatment ... severe disease If relapse ... #Anemia #AIHA #Treatment
Lymphomas and Lymphoproliferative Disorders - Differential Diagnosis Algorithm
Hodgkin Lymphoma ~40% - Characteristic For Reed-Sternberg (RS) Cells
Responsive to Treatment ... growth, response to treatment ... and relapse
Alcohol Use Disorder - Maintenance Treatment
Naltrexone (first line) - First line for most people without contraindications
- Maintenance Treatment ... abstaining, prevents relapse ... abstaining, prevents relapse ... family, opioid treatment ... #Maintenance #Treatment
Acid Reflux - Management Algorithm
 - Step down and stop; restart on lowest effective dose if
effective dose if relapse ... diagnosis when treatment
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
with multiple relapses ... Leishmaniasis #Prevention #Treatment
Babesiosis - Diagnosis and Management Summary 
Disease: Release of merozoites from erythrocytes and associated loss of
Treatment: • Immunocompetent ... Patient with risk of relapse ... to 2 weeks • Relapse